Select language:

DHG-Japanese pharmaceutical giant want to acquire more capital in Hau Giang Pharmaceutical

Tuesday - 05/06/2018 07:50
Taisho Pharmaceutical - the pharmaceutical company of Japan - is the largest foreign shareholder in Hau Giang Pharmaceutical.
dhg chart

Taisho Pharmaceutical, a unit of Taisho Pharmaceutical Holdings, has registered to buy 650,000 shares (equivalent to 0.5% of capital) of Hau Giang Pharmaceutical Joint Stock Company (DHG).

This enterprise is currently the largest foreign shareholder of Hau Giang Pharmaceutical with 24.44% of charter capital. Accordingly, if the transaction is successful, Taisho Pharmaceutical will increase its ownership to 32.6 million shares, equivalent to nearly 25% of charter capital.

The transaction is scheduled from June 6 to July 6 through order matching or agreement. Estimated at the close price of DHG shares, Taisho will spend more than 67 billion.

According to the management report of Hau Giang Pharmacy, the largest shareholder of this business is the State Capital Investment Corporation (SCIC). By the end of 2017, SCIC owns more than 56.6 million shares, equivalent to more than 43.3% of charter capital.

Total notes of this article: 0 in 0 rating

Click on stars to rate this article

  Reader Comments

About us

We provide the leading securities investment consulting services in Vietnam. We provide a great deal of professional advice, governance and professional securities trading services to our clients in Vietnam. We combine the spirit of accountability, the insight of each featured enterprise,...

You did not use the site, Click here to remain logged. Timeout: 60 second